| Ed Bout and Dave Hasselaar Mp3, Ed Bout and Dave Hasselaar Music Lyrics
| |
Ed Bout and Dave Hasselaar biography, Ed Bout and Dave Hasselaar discography
Critical Mass was formed in 1994 by 2 Gabbaproducers, Ed Bout and Dave Hasselaar.At the beginning both producers where the act by themselves but not much later they integrated
the singer Ludmilla Odijk and the rapper Danny Haenraets alias MC Energy.At the end of 1995 they got a hit with "Dancin' Together".In 1996 3 big hits followed: "Burnin' Love", "Believe In The Future" and
"Happy Generation".But they had big popularity at raves and gabba parties.The Summer of 1997 was the
highlight of gabba music but in the autumn of that year it fell down.But even Byte failed to make Critical Mass succeed.When hardcore began to live again in the underground Ed and Dave decided to quit
with it and go back to their roots.Your Eyes" ("In Your Eyes") was released in Spain by Virtual Records in 2003.Happy Generation (Radio Edit)
Happy Generation (Extended Mix)
Happy Generation (Trimix)
Happy Generation (Deaz.The Global Electronic Music Marketplace
Amazon.Biography and parts of discography provided by Rogier Verkroost 2002
Additional information and corrections by Ruslan L.Thanks to Jan Rasmussen for some discography information.Thanks to DJ Hooligan for some discography information.Later sloot Ludmilla (zangeres) en MC Energy zich ook bij de groep aan.Samen besluiten zij een nieuwe groep op te richten.Critical Mass spoedig samen wordt gevoegd met 2 Unlimited.In 1997, wanneer de happy hardcore rage in Nederland langzaam zijn einde nadert, brengt de groep de single Together In Dreams uit.Voor delen van dit artikel is de biografie op Popinstituut gebruikt.Deze pagina is het laatst bewerkt op 13 apr 2008 om 00:55.De tekst op Wikipedia is zonder enige vorm van garantie beschikbaar onder de GNU Free Documentation License.In de jaren erna, wanneer de happy hardcore rage in Nederland langzaam zijn einde nadert, brengt de groep de single Together In Dreams uit.De scene verdween, maar is nu weer helemaal in opkomst en Critical Mass is sterker dan ooit terug!!Act zet enkele stage in vuur en vlam en een must to get back from the good old days!!Exclusive offers, news and more.World War II Days: Discover the Past with Exciting Projects, Games, Activities, and Recipes
by David C.This price is valid for United States.Other Outrageous Women of the Renaissance.You are seeing this message because your Web browser does not support basic Web standards.Is Aspirin Resistance Due to Noncompliance?Lists editorial and production staff, editorial board, and other information.XVlth Congress of the ISTH, Washington, D.XVllth Congress of the ISTH, Washington, D.VI deficiency in a mouse model of arterial thrombosis.In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice.Lippincott, Williams and Wilkens Publishers.Generation of a new integrin inhibitor.The FASEB Journel express article 10.Published online May 31 (2005).Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.Inhibition of endogenous leptin protects mice from arterial and venous thrombosis.Angiogenesis in an in vivo model of adipose tissue development.Regulation of plasminogen gene expression.Plasminogen: Structure, Activation, and Regulation.Identification of the disulfide bonds in the recombinant somatomedin B domain of human vitronectin.The exact role of the fibrinolytic system in vascular remodeling remains uncertain.In: Vascular Protection: Molecular Mechanisms, Novel Therapeutic Principles and Clinical Application.Kinetic analysis of the interaction between vitronectin and the urokinase receptor.Tissue distribution of Factor VIII gene expression in vivo; A closer look.Regulation of tissue factor gene expression in obesity.The Fifth Saratoga International Conference.New Frontier in Vascular Biology; Thrombosis and Hemostasis, Suzuki, K.RW Colman, J Hirsh, VJ Marder, A W Clowes, JN George.Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.The adipocyte and hemostatic balance in obesity: Studies of plasminogen activator inhibitor 1.Extrahepatic expression and regulation of protein C in the mouse.VCH Verlag GmbH, Weinheim, 1997.Mechanisms of elevated plasminogen activator inhibitor 1 in obesity.Expression of fibrinolytic genes in tissues from human atherosclerotic aneurysms and from obese mice.Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.In: Advances in Vascular Biology, Vadas, M.Tissue factor expression during human and mouse development.Tissue distribution and regulation of plasminogen activator inhibitor 1 in obese mice.Differential regulation of vitronectin in mice and humans in vitro.Endotoxin stimulates expression of the murine urokinase receptor gene in vivo.Murine CD14 gene expression in vivo: Extramyeloid synthesis and regulation by lipopolysaccharide.Carboxypeptidases: New Regulators of Plasminogen Activation In Vivo?In: Fibrinolysis in Disease: Molecular and Hemovascular Aspects of Fibrinolysis.CRC Press, Boca Raton, FL, p.Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall: A possible mechanism for aneurysm expansion.Distribution of vitronectin mRNA during murine development.Cellular and Molecular Mechanisms, Prevention, and Treatment.Cellular expression and potential roles of plasminogen activator inhibitors (PAIs) in normal and pathological pregnancies.Grupo Masson, Madrid, Spain, p.Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli.Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis.Vitronectin gene expression in vivo: Evidence for extrahepatic synthesis and acute phase regulation.In: Biology of Vitronectins and Their Receptors.Expression of fibrinolytic genes by cells of the vascular wall.Westfaelische Academy of Science, Hauss, W.Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis.Type 1 plasminogen activator inhibitor gene expression following partial hepatectomy.In situ hybridization: New approaches for the in vivo localization of fibrinolytic components.In: Transgenic Animal Models in Biomedical Research.SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells.The biochemistry, cell and molecular biology of type 1 plasminogen activator inhibitor.In: Vascular Endothelium: Physiological Basis of Clinical Problems.In: Thrombolysis: Basic Contributions and Clinical Progress.Regulation of type one plasminogen activator inhibitor gene expression in cultured endothelial cells and the vessel wall.Atherosclerosis: Cellular and Molecular Interactions in the Artery Wall.Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo.Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.In: Trends in Cardiovascular Medicine.The role of type 1 plasminogen activator inhibitor in the regulation of the fibrinolytic system of the normal and atherosclerotic vessel wall.Proceedings of the Rheinisch Westfaelische Academy of Science Vol.Regulation of type 1 plasminogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells.Inhibitors of urokinase and thrombin in cultured neural cells.The cell and molecular biology of plasminogen activator inhibitors.The cell and molecular biology of type 1 plasminogen activator inhibitor.The fibrinolytic system of the vessel wall and its role in the control of thrombosis.Recent Progress in Atherosclerosis Research.The Second Saratoga International Conference on Atherosclerosis in Towada.Recommendations for the nomenclature of mutant fibrinolytic genes and their proteins.Report of the SSC Fibrinolysis Subcommittee 1990.Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system.Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cells.Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix: Evidence that the protein is vitronectin.Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.The fibrinolytic system of cultured endothelial cells.Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.Divergent responses in lung fibroblasts and carcinoma cells.Type 1 plasminogen activator inhibitor and its potential influence on thrombolytic therapy.Plasminogen activators and their inhibitors.Type 1 plasminogen activator inhibitor.The fibrinolytic system of endothelial cells.Structure of the human plasminogen activator inhibitor 1 gene: Nonrandom distribution of introns.Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.In: Cardiovascular Disease: Molecular and Cellular Mechanisms, Prevention, and Treatment.The fibrinolytic system of cultured endothelial cells: Insights into the role of endothelium in thrombolysis.In: Vascular Endothelium in Hemostasis and Thrombosis.Fibrinolytic system of cultured endothelial cells: Regulation by plasminogen activator inhibitor.Role of plasminogen activator inhibitor.Messenger RNA for plasminogen activator inhibitor.The fibrinolytic system of the Vascular Wall.Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.The fibrinolytic system of cultured endothelial cells: Deciphering the balance between plasminogen activation and inhibition.Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.The Biology of Endothelial Cells.Martinus Nijhoff Publishers, The Netherlands, p.Activation of Hageman factor by cultured rabbit endothelial cells.Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells.Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.Review of clotting and the differences between plasma and serum that might be significant to cell culture.Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.Comparative studies of the fibrinolytic activity of cultured vascular cells.Effect of thrombin on the fibrinolytic activity of cultured bovine endothelial cells.Intracellular plasminogen activator activity in growing and quiescent cells.Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.Proteases associated with malignant transformation.Cytochrome oxidase repair during treatment of copper deficiency: Relation to mitochondrial turnover.
|
| |
|
 |
|
